相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The Impact of Diabetic Conditions and AGE/RAGE Signaling on Cardiac Fibroblast Migration
Stephanie D. Burr et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
TGF-β in renal fibrosis: triumphs and challenges
Yue-Yu Gu et al.
FUTURE MEDICINAL CHEMISTRY (2020)
Macrophages: versatile players in renal inflammation and fibrosis
Patrick Ming-Kuen Tang et al.
NATURE REVIEWS NEPHROLOGY (2019)
Liraglutide, a Glucagon-like Peptide-1 Receptor Agonist, Attenuates Development of Cardiac Allograft Vasculopathy in a Murine Heart Transplant Model
ZhiMin Wang et al.
TRANSPLANTATION (2019)
Cardiac Allograft Vasculopathy A Formidable Foe
Chetan B. Patel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
LMO7 Is a Negative Feedback Regulator of Transforming Growth Factor Signaling and Fibrosis
Yi Xie et al.
CIRCULATION (2019)
miR-627/HMGB1/NF-κB regulatory loop modulates TGF-β1-induced pulmonary fibrosis
Jie Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts
Felipe Tapia Caceres et al.
FASEB JOURNAL (2019)
New insights into TGF-β/Smad signaling in tissue fibrosis
He-He Hu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
The role of HMGB1 in heart transplantation
Qianying Lv et al.
IMMUNOLOGY LETTERS (2018)
Glycyrrhizin Protects Mice Against Experimental Autoimmune Encephalomyelitis by Inhibiting High-Mobility Group Box 1 (HMGB1) Expression and Neuronal HMGB1 Release
Yan Sun et al.
FRONTIERS IN IMMUNOLOGY (2018)
1 Recent advances in allograft vasculopathy
Jonathan Merola et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2017)
Anti-TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
James Voelker et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
HMGB1 induces lung fibroblast to myofibroblast differentiation through NF-κB-mediated TGF-β1 release
Qiong Wang et al.
MOLECULAR MEDICINE REPORTS (2017)
HMGB1, TGF-β and NF-κB are associated with chronic allograft nephropathy
Shi-Qi Zhao et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Transforming growth factor-: A therapeutic target for cancer
Sulsal Haque et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathy
Yiyang Yue et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
M2 macrophages induce EMT through the TGF-/Smad2 signaling pathway
Liangying Zhu et al.
CELL BIOLOGY INTERNATIONAL (2017)
Basophils Trigger Fibroblast Activation in Cardiac Allograft Fibrosis Development
G. Schiechl et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
HMGB1 blockade differentially impacts pulmonary inflammation and defense responses in poly(I:C)/LPS-exposed heart transplant mice
Bingxia Ming et al.
MOLECULAR IMMUNOLOGY (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
Transforming growth factor beta (TGF-β) isoforms in wound healing and fibrosis
Michael K. Lichtman et al.
WOUND REPAIR AND REGENERATION (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
HMGB1 Enhances the AGE-Induced Expression of CTGF and TGF-β via RAGE-Dependent Signaling in Renal Tubular Epithelial Cells
Meichu Cheng et al.
AMERICAN JOURNAL OF NEPHROLOGY (2015)
Blockade of Extracellular HMGB1 Suppresses Xenoreactive B Cell Responses and Delays Acute Vascular Xenogeneic Rejection
J. -H. Li et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
HMGB1 Is Involved in Chronic Rejection of Cardiac Allograft via Promoting Inflammatory-Like mDCs
H. Zou et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
RIPK3-Mediated Necroptosis Regulates Cardiac Allograft Rejection
A. Pavlosky et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Increase in Hypotonic Stress-Induced Endocytic Activity in Macrophages via ClC-3
Yutao Yan et al.
MOLECULES AND CELLS (2014)
High-mobility group box 1 accelerates early acute allograft rejection via enhancing IL-17+ γδ T-cell response
Quansong Xia et al.
TRANSPLANT INTERNATIONAL (2014)
Host Responses in Tissue Repair and Fibrosis
Jeremy S. Duffield et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 8 (2013)
Four Decades of Vascularized Heterotopic Cardiac Transplantation in the Mouse
Robert J. Plenter et al.
JOURNAL OF INVESTIGATIVE SURGERY (2013)
Recent Developments in Myofibroblast Biology Paradigms for Connective Tissue Remodeling
Boris Hinz et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
HMGB1 is an independent predictor of death and heart transplantation in heart failure
H. C. Volz et al.
CLINICAL RESEARCH IN CARDIOLOGY (2012)
High-mobility group box 1 promotes early acute allograft rejection by enhancing IL-6-dependent Th17 alloreactive response
Lihua Duan et al.
LABORATORY INVESTIGATION (2011)
Mechanism of arterial remodeling in chronic allograft vasculopathy
Qichang Zheng et al.
Frontiers of Medicine (2011)
Understanding the role of transfonning growth factor-β 1 in intimal thickening after vascular injury
Razi Khan et al.
CARDIOVASCULAR RESEARCH (2007)
Extracellular Hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection
Y. Huang et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Contribution of adventitial fibroblasts to neointima formation and vascular remodeling - From innocent bystander to active participant
S Sartore et al.
CIRCULATION RESEARCH (2001)